In this study, we found that the expression of TNFAIP2 in AML samples was obviously lower than that in normal bone marrow samples in the GSE9476 dataset, and this result was confirmed in another independent cohort in the Oncomine database. This evidence concerns the gene TNFAIP2 and acute myeloid leukemia.